News

US junk bond yield hits record lows on coronavirus vaccine hopes

The average yield for the Bloomberg Barclays US corporate high yield index tanked by 45 basis points to a record low of 4.56% on Monday as coronavirus vaccine hopes boosted risk appetite and demand for riskier companies. 

Monday's slide was the biggest single-day decline since April 9, when the Federal Reserve expanded its corporate bond purchases to include some junk debt, according to Bloomberg. The previous record low of 4.83% was set in June 2014.

While the junk bond yield reached record lows, the yield on the 10-year Treasury yield jumped over 10 basis points to 0.97%, the highest since March 20. Further, the yield curve reached its steepest level since March. The data indicates investors rotated money out of safe havens and into risk assets. 

The investor sentiment was buoyed by reports that a large-scale study for a coronavirus vaccine developed by Pfizer Inc. and BioNTech SE prevented over 90% of infections.


 

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.